Literature DB >> 2209667

Surfactant treatment for respiratory distress syndrome following prolonged rupture of membranes.

T R Tubman1, H L Halliday.   

Abstract

Surfactant replacement for respiratory distress syndrome (RDS) following very prolonged rupture of the membranes (PROM) is of uncertain value. Seven preterm babies born after PROM (median 48 days, range 22-61 days) were compared with 14 babies without PROM. All had clinical and radiological evidence of severe RDS, requiring mechanical ventilation with inspired oxygen concentrations greater than or equal to 60%. Indices of oxygenation and "compliance" were compared before and serially up to 4 h after surfactant treatment. Before treatment the PROM babies had more severe lung disease, based upon higher inspired oxygen concentration and mean airway pressure, and lower arterial/alveolar oxygen tension ratio and ventilator efficiency index. These indices were significantly worse in the PROM group than the comparison group at all times after treatment. The poor response of the PROM group, perhaps because of pulmonary hypoplasia, suggests that surfactant replacement may not be beneficial for RDS in these babies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2209667     DOI: 10.1007/bf01959532

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  Acute effects of instillation of surfactant in severe respiratory distress syndrome.

Authors:  H L Halliday; F B McCord; B G McClure; M M Reid
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

2.  Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.

Authors: 
Journal:  Pediatrics       Date:  1988-11       Impact factor: 7.124

3.  Neonatal pulmonary hypoplasia after prolonged leakage of amniotic fluid.

Authors:  M Perlman; J Williams; M Hirsch
Journal:  Arch Dis Child       Date:  1976-05       Impact factor: 3.791

4.  Decreased surfactant level in the lung with oligohydramnios: a morphometric and biochemical study.

Authors:  Y Nakamura; I Yamamoto; Y Funatsu; K Motomura; S Fukuda; T Hashimoto; M Morimatsu
Journal:  J Pediatr       Date:  1988-03       Impact factor: 4.406

5.  Neonatal pulmonary hypoplasia with premature rupture of fetal membranes and oligohydramnios.

Authors:  D W Thibeault; E C Beatty; R T Hall; S K Bowen; D H O'Neill
Journal:  J Pediatr       Date:  1985-08       Impact factor: 4.406

6.  Lung surfactant replacement in premature lambs with extracted lipids from bovine lung lavage: effects of dose, dispersion technique, and gestational age.

Authors:  R H Notter; E A Egan; M S Kwong; B A Holm; D L Shapiro
Journal:  Pediatr Res       Date:  1985-06       Impact factor: 3.756

7.  Severe neonatal respiratory distress syndrome treated with the isolated phospholipid fraction of natural surfactant.

Authors:  G Noack; P Berggren; T Curstedt; G Grossmann; P Herin; W Mortensson; R Nilsson; B Robertson
Journal:  Acta Paediatr Scand       Date:  1987-09

8.  The effects of preterm delivery and mechanical ventilation on human lung growth.

Authors:  A A Hislop; J S Wigglesworth; R Desai; V Aber
Journal:  Early Hum Dev       Date:  1987-05       Impact factor: 2.079

9.  Pulmonary hypoplasia: lung weight and radial alveolar count as criteria of diagnosis.

Authors:  S S Askenazi; M Perlman
Journal:  Arch Dis Child       Date:  1979-08       Impact factor: 3.791

10.  Fetal lung hypoplasia: biochemical and structural variations and their possible significance.

Authors:  J S Wigglesworth; R Desai; P Guerrini
Journal:  Arch Dis Child       Date:  1981-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.